WALTHAM, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO) announced today that Paul M. Meister, chairman
of the board, and certain executive officers, including Marijn E. Dekkers,
chief executive officer, have adopted stock-trading programs under
Securities and Exchange Commission (SEC) Rule 10b5-1 covering the future
sale of company stock. Mr. Meister has adopted a plan for the sale of up to
2,250,000 shares. Mr. Dekkers has adopted a plan for the sale of up to
1,046,660 shares, which he would acquire upon the exercise of a stock
option that was granted when he joined the company in 2000 and expires in
July 2007.
After selling these shares, Mr. Meister would own shares or hold
options totaling 2,250,400 shares. Mr. Dekkers would own shares, or share
equivalents, and hold options totaling 2,935,378 shares.
These trading programs are based on SEC Rule 10b5-1, which protects
company executives from possible claims of insider trading by permitting
them to buy or sell a predetermined amount of their company's shares, as
set forth in a planned acquisition or divestiture program that was adopted
when the insider did not possess any material non-public information.
About Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE: TMO) is the world leader in serving
science, enabling our customers to make the world healthier, cleaner and
safer. With annual sales of more than $9 billion, we employ 30,000 people
and serve over 350,000 customers within pharmaceutical and biotech
companies, hospitals and clinical diagnostic labs, universities, research
institutions and government agencies, as well as environmental and
industrial process control settings. Serving customers through two premier
brands, Thermo Scientific and Fisher Scientific, we help solve analytical
challenges from routine testing to complex research and discovery. Thermo
Scientific offers customers a complete range of high-end analytical
instruments as well as laboratory equipment, software, services,
consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of laboratory
equipment, chemicals, supplies and services used in healthcare, scientific
research, safety and education. Together, we offer the most convenient
purchasing options to customers and continuously advance our technologies
to accelerate the pace of scientific discovery, enhance value for customers
and fuel growth for shareholders and employees alike. Visit
http://www.thermofisher.com.
Media Contact Information:
Lori Gorski
Phone: 781-622-1242
E-mail: lori.gorski@thermofisher.com
Website: http://www.thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1111
E-mail: ken.apicerno@thermofisher.com
SOURCE Thermo Fisher Scientific Inc.
 back to top
Related links:
http://www.thermofisher.com
http://www.prnewswire.com/comp/877850.html/
CONTACT:
Media Contact: Lori Gorski, +1-781-622-1242,
lori.gorski@thermofisher.com, or Investor Contact: Ken Apicerno,
+1-781-622- 1111, ken.apicerno@thermofisher.com
|
